Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mackenzie Innovation Institute (Mi2) is the innovation arm of Mackenzie Health, a major healthcare provider in Ontario, Canada. Mi2 is dedicated to advancing the "Smart Hospital" vision by developing, testing, and implementing cutting-edge digital health solutions and medical technologies. The institute serves as a living laboratory where industry partners can collaborate with clinicians to validate innovations in a real-world clinical setting. Key focus areas include artificial intelligence, clinical workflow automation, and integrated medical device ecosystems designed to enhance patient safety and provider efficiency. By bridging the gap between technology developers and healthcare delivery, Mi2 aims to transform the patient and provider experience through data-driven insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mackenzie Innovation Institute.